NEWS
View news from our Featured Companies.
S&W Seed Company to Report Fourth Quarter and Fiscal Year 2024 Financial Results on Friday, November 1, 2024
Conference call to be conducted on Friday, November 1, 2024, at 11:00 a.m. ET LONGMONT, Colo., Oct. 31, 2024 -- S&W Seed Company (Nasdaq: SANW) will report financial results for its fourth quarter and fiscal year 2024, ended June 30, 2024, on Friday, November 1,...
ChromaDex Corporation Reports Third Quarter 2024 Financial Results
Total net sales of $25.6 million, up $6.1 million or 31% year-over-year, gross margin of 63.5% and record net income and adjusted EBITDA of $1.9 million and $2.9 million, respectively, for the three months ended September 30, 2024 LOS ANGELES - ChromaDex Corp....
Evolve™ Registered in Hong Kong; Offering a Revolutionary Non-Lethal Rodent Control Solution
PHOENIX, Oct. 31, 2024 -- SenesTech, Inc. (Nasdaq: SNES), the leader in birth control to manage rodent pest populations, today announces the successful registration of Evolve™ in Hong Kong. A Sustainable and Humane Approach to Rodent Control Hong Kong welcomes...
Reviva to Participate in the UBS Global Healthcare Conference
CUPERTINO, Calif., Oct. 31, 2024 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
IRADIMED CORPORATION Announces Third Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
Reports record revenue of $18.3 million for the third quarter of 2024, an increase of $1.8 million or 11% over the comparable period 2023.Reports GAAP diluted EPS of $0.40 and Non-GAAP diluted EPS of $0.43 for the third quarter of 2024.Raising year end guidance on...
InfuSystem to Report Third Quarter 2024 Financial Results on November 7, 2024
Investor Conference Call to be held 9:00 a.m. Eastern Time ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical...
PolyPid to Report Third Quarter 2024 Financial Results and Operational Highlights on November 13, 2024
PETACH TIKVA, Israel, Oct. 30, 2024 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its third quarter 2024 financial results and operational highlights...
NeurAxis Announces Capital Blue Cross Medical Policy Coverage for PENFS, effective October 1st 2024
CARMEL, Ind., Oct. 29, 2024 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced medical...
Precision Optics Customer Receives FDA 510(k) Clearance; Accelerates Production Order for POC Single-Use Endoscope Imaging Assembly
GARDNER, Mass., Oct. 29, 2024 -- Precision Optics Corporation, Inc. (NASDAQ: POCI) ("POC"), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced that its customer, a surgical robotics company...
Kiora Pharmaceuticals Receives Investigational New Drug Approval to Initiate ABACUS-2, a Phase 2 Clinical Trial of KIO-301 for the Treatment of Retinitis Pigmentosa
Encinitas, California--(October 29, 2024) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced it received regulatory approval to initiate a Phase 2 clinical trial to investigate KIO-301 for vision restoration in patients with...
ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024
LOS ANGELES - ChromaDex Corp. (NASDAQ: CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, announced that it has rescheduled its previously announced conference call to Thursday, October 31, 2024 at 4:30 p.m....
Mogo to Announce Q3 2024 Financial Results November 6, 2024
VANCOUVER, British Columbia - Mogo Inc. (TSX:MOGO) (NASDAQ:MOGO) ("Mogo" or the "Company"), a digital wealth and payments business, today announced it will hold a conference call and webcast to discuss its Q3 2024 financial results on Wednesday, November 6, 2024 at...
Acasti Announces Corporate Name Change to Grace Therapeutics, Inc.
Name Change Reflects Extensive Scientific and Corporate Brand Equity Previously Established under Grace Therapeutics Grace Therapeutics will begin trading on Nasdaq under the trading symbol "GRCE" effective October 28, 2024 Virtual Key Opinion Leader Event to be held...
IRADIMED CORPORATION to Hold 2024 Third Quarter Financial Results Conference Call on October 31st
WINTER SPRINGS, Fla., Oct. 24, 2024 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 third quarter financial results before the market opens on Thursday, October 31, 2024. Iradimed management will host a conference call the...
Cadrenal Therapeutics Raises $5.1 Million via At-The-Market Facility
PONTE VEDRA, Fla., Oct. 24, 2024 -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD) (the "Company" or "Cadrenal"), a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) designed to offer safer, superior chronic anticoagulation for...
ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024
LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, announced that it will hold a conference call on Wednesday, November 6, 2024 at 4:30 p.m. ET. to discuss its financial...
S&W Seed Company Receives Notice of Nasdaq Non-Compliance with Listing Rule 5250(c)(1)
LONGMONT, Colo., Oct. 23, 2024 -- S&W Seed Company (Nasdaq: SANW) announced that, on October 17, 2024, the Company received a notice from the Listing Qualifications Staff of The Nasdaq Stock Market (Nasdaq), advising the Company that its failure to timely file its...
CADRENAL THERAPEUTICS JOINS CORPORATE COUNCIL OF ANTICOAGULATION FORUM
Participation Reinforces Cadrenal's Commitment to Innovation, Education and Improved Patient Outcomes with Anticoagulation Therapy PONTE VEDRA, Fla., Oct. 23, 2024 -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company developing...
ChromaDex to Participate in the 17th Annual LD Micro Main Event
LOS ANGELES - ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, announced that it will be participating at the 17th Annual LD Micro Main Event at the Luxe Sunset Boulevard Hotel,...
NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field Stimulation
CARMEL, Ind., Oct. 22, 2024 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, announced that the...
INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences
New Trading Symbol "NAYA" Effective Tuesday October 22, 2024SARASOTA, Fla. and MIAMI, Oct. 21, 2024 -- INVO Biosciences (Nasdaq: INVO), a company focused on expanding its portfolio of clinical and commercial-stage assets in fertility, oncology, and autoimmune diseases...
PolyPid Announces Publication in International Journal of Surgery Highlighting Results of Phase 3 SHIELD I Trial of D-PLEX in Prevention of Surgical Site Infections in Abdominal Colorectal Surgery
SHIELD I Study is One of the Largest Phase 3 Trials in the Prevention of SSIs in Colorectal Resection Conducted in Over a Decade Pre-Specified and Post-Hoc Analyses Suggested that D-PLEX100 May Benefit Patients with Increased SSI Risk, Including Those with Lengthy...
ARIANNE PHOSPHATE RECEIVES FINAL ACCEPTANCE FOR ITS PREVIOUSLY ANNOUNCED STRATEGIC INVESTMENT FROM A GLOBAL MINING COMPANY
DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTCQX (USA) SAGUENAY, QC, Oct. 17, 2024 /CNW/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTCQX: DRRSF) (FRANKFURT: JE9N), a development-stage phosphate mining company, advancing the Lac à Paul...
S&W Seed Company Provides Update on Delay of Form 10-K Filing for Fiscal Year 2024
LONGMONT, Colo., Oct. 16, 2024 -- S&W Seed Company (Nasdaq: SANW) today provided an update with respect to the Late Filing of its Annual Report on Form 10-K for the fiscal year ended June 30, 2024. The Company is continuing to work through reporting requirements...
Textile Industry Adopts New International Standard for Measuring Microplastics
Aquafil SPA Integral to The Standard's AdoptionARCO, Italy, Oct. 16, 2024 -- Aquafil SpA (ECNLF:OTCQX - ECNL:IM), based in Arco (TN) Italy and a pioneer of the circular economy, today released its third in a series of monographs illustrating how we can design better...